Jun 3, 2004 by Brian GormanSpitzer Chases GlaxoDid the drug company withhold information about the effects of Paxil in children?
Jun 3, 2004 by Brian GormanMesa's Flight PathMesa Air's traffic and metrics look good, but the company faces uncertainty.
Jun 2, 2004 by Brian GormanNew Injection for GenzymeA partnership with Medtronic bolsters Genzyme's myoblast cell therapy program.
Jun 2, 2004 by Brian GormanKraft Rethinks PortionsThe change of heart makes sense, but it may pay to be bolder.
Jun 1, 2004 by Brian GormanCadbury's New PopCadbury is joining the alternative soda fray, but it's unclear where its new drink will fit in.
May 28, 2004 by Brian GormanYahoo! Aims at SpywareYahoo! continues to show its agility by introducing an anti-spyware feature to its toolbar.
May 27, 2004 by Brian GormanCUNO Drinks in WTCThe purchase of WTC Industries will pump up the company's already-strong potable water business.
May 26, 2004 by Brian GormanToro's Grass Is GreenToro's earnings continue to climb as it mows down expenses and introduces new products.
May 25, 2004 by Brian GormanOmnicare Keeps BuyingThe firm may be stretching itself thin with ongoing purchases.
May 24, 2004 by Brian GormanAbbott Labs Stirs Up CriticismWith politicians and the public riled up about Medicare, Abbott hiked the cost of an HIV drug. Smart move?
May 21, 2004 by Brian GormanHormel Brings Home the BaconTrends for the company look good, but the stock is pricey.
May 20, 2004 by Brian GormanPetco's Good BehaviorThe company deserves a treat for its first-quarter showing, but investors should keep it on a short leash.
May 19, 2004 by Brian GormanU.N. Plants Seed for AgribusinessIts endorsement of biotech foods could clear the way for agribusiness in the developing world.
May 18, 2004 by Brian GormanSabre Rattled?Orbitz's push to expand Supplier Link is bad news for Sabre.
May 17, 2004 by Brian GormanBoeing's ChallengeBoeing's focus on the 7E7 is the right path for now, but the firm will have to confront the challenge from Airbus' A380.
May 13, 2004 by Brian GormanDaimler's Wise RetreatThe automaker's withdrawal from several joint ventures in Asia should help in the long run.
May 12, 2004 by Brian GormanProcter & Gamble Bets on ChinaThe consumer products powerhouse looks like it's making all the right moves.
May 11, 2004 by Brian GormanMonsanto's Fallow Wheat FieldMonsanto's halts development of its controversial genetically modified spring wheat.
May 10, 2004 by Brian GormanU.S. Airways' TailspinThe struggling airline is getting pummeled from all fronts. Can it survive?
May 7, 2004 by Brian GormanCVS Fuels the Drug DebateCVS supports the controversial topic of drug reimportation.
